Obsidian Therapeutics, Inc.
OBX
$18.68
-$0.05-0.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 34.45M | 58.76M | -- | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 11.91M | 4.58M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | 700.00K | -- | ||
| Total Current Assets | 46.36M | 64.04M | -- | ||
|
|
|||||
| Total Current Assets | 46.36M | 64.04M | -- | ||
| Net Property, Plant & Equipment | 4.08M | 5.09M | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 1.00M | 1.00M | -- | ||
| Total Assets | 51.44M | 70.14M | -- | ||
|
|
|||||
| Total Accounts Payable | 365.00K | 738.00K | -- | ||
| Total Accrued Expenses | 15.65M | 10.38M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 1.98M | 2.53M | -- | ||
| Total Finance Division Other Current Liabilities | 2.20M | 1.58M | -- | ||
| Total Other Current Liabilities | 2.20M | 1.58M | -- | ||
| Total Current Liabilities | 20.20M | 15.23M | -- | ||
|
|
|||||
| Total Current Liabilities | 20.20M | 15.23M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 928.00K | 1.07M | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 1.00K | 3.00K | -- | ||
| Total Liabilities | 21.13M | 16.31M | -- | ||
|
|
|||||
| Common Stock & APIC | 41.72M | 39.38M | -- | ||
| Retained Earnings | -341.43M | -315.57M | -- | ||
| Treasury Stock & Other | -3.00K | -5.00K | -- | ||
| Total Common Equity | -299.71M | -276.20M | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | 330.03M | 330.03M | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | 330.03M | 330.03M | -- | ||
|
|
|||||
| Total Common Equity | -299.71M | -276.20M | -- | ||
| Total Preferred Equity | 330.03M | 330.03M | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 30.32M | 53.83M | -- | ||
|
|
|||||